Don Kellerman, PharmD
Zosano Pharma Corporation
3
0
3
N/A
0
2
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Michael B Gill
Power Life Sciences Inc.
Shared therapeutic areas:
Anissa MEGZARI
Centre Hospitalier Universitaire de Nīmes
Shared therapeutic areas:
Mireille Michel-Cherqui, MD
Hopital Foch
Shared therapeutic areas:
Gregory Flippo, MD
Alabama Clinical Therapeutics
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Craig LaForce, MD
North Carolina Clinical Research
Shared therapeutic areas:
Brendan Smyth
AstraZeneca
Shared therapeutic areas:
Urielle Desalbres
Assistance Publique Hôpitaux de Marseille
Shared therapeutic areas:
Stephan Sharp, MD
Clinical Research Associates, Inc.
Shared therapeutic areas:
Hakan Gürpınar
Humanis Saglık
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Study of PK, Safety, and Tolerability of 2 Lots of M207 & Intranasal Zolmitriptan in Healthy Volunteers
Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches
A Four-way Crossover Study of 3 Formulations of M207 With Intranasal Zolmitriptan in Healthy Volunteers
All 3 trials loaded